Literature DB >> 11105995

Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma.

A Asai1, T Miyazawa.   

Abstract

Curcuminoids, curcumin and its structurally related compounds, constitute the phenolic yellowish pigment of turmeric. We investigated the absorption and metabolism of orally administered curcuminoids (curcumin, demethoxycurcumin and bisdemethoxycurcumin) in rats. HPLC and LC-MS analyses after enzymatic hydrolyses showed that the predominant metabolites in plasma following administration were glucuronides and glucuronide/sulfates (conjugates with both glucuronide and sulfate) of curcuminoids. The plasma concentrations of conjugated curcuminoids reached a maximum one hour after administration. The conjugative enzyme activities for glucuronidation and sulfation of curcumin were found in liver, kidney and intestinal mucosa. These results indicate that orally administered curcuminoids are absorbed from the alimentary tract and present in the general blood circulation after largely being metabolized to the form of glucuronide and glucuronide/sulfate conjugates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105995     DOI: 10.1016/s0024-3205(00)00868-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  55 in total

1.  Examination of the pharmacokinetics of active ingredients of ginger in humans.

Authors:  Yanke Yu; Suzanna Zick; Xiaoqin Li; Peng Zou; Benjamin Wright; Duxin Sun
Journal:  AAPS J       Date:  2011-06-03       Impact factor: 4.009

Review 2.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Administering Fixed Oral Doses of Curcumin to Rats through Voluntary Consumption.

Authors:  Ashleigh J Hocking; David Elliot; Jin Hua; Sonja Klebe
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-08-29       Impact factor: 1.232

4.  A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma.

Authors:  Wei Chen; Patty Fan-Havard; Lisa D Yee; Yu Cao; Gary D Stoner; Kenneth K Chan; Zhongfa Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-05-26       Impact factor: 3.205

Review 5.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

6.  Analysis of the in vitro metabolites of diferuloylmethane (curcumin) by liquid chromatography--tandem mass spectrometry on a hybrid quadrupole linear ion trap system: newly identified metabolites.

Authors:  Constantin Tamvakopoulos; Zacharias D Sofianos; Spiros D Garbis; Panayotis Pantazis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

7.  Quantitation of 6-, 8- and 10-Gingerols and 6-Shogaol in Human Plasma by High-Performance Liquid Chromatography with Electrochemical Detection.

Authors:  Suzanna M Zick; Mack T Ruffin; Zora Djuric; Daniel Normolle; Dean E Brenner
Journal:  Int J Biomed Sci       Date:  2010-09

8.  Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects.

Authors:  Suzanna M Zick; Zora Djuric; Mack T Ruffin; Amie J Litzinger; Daniel P Normolle; Sara Alrawi; Meihua Rose Feng; Dean E Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

9.  Study of interaction of human serum albumin with curcumin by NMR and docking.

Authors:  Durg Vijay Singh; Santosh Kumar Bharti; Shikha Agarwal; Raja Roy; Krishna Misra
Journal:  J Mol Model       Date:  2014-07-17       Impact factor: 1.810

10.  A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin.

Authors:  B Antony; B Merina; V S Iyer; N Judy; K Lennertz; S Joyal
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.